Novanta Inc (NOVT) - Aggregate Business Assets

NOVT (Novanta Inc) - company brandmark

Novanta Inc. generates revenue through the production of precision automation and lasers, creating a steady profit stream via deep integration into medtech. Risks are linked to a potential decline in equipment investment and technological obsolescence. An assessment of controlled resources demonstrates asset dynamics, where the 1827.22 metric indicates the capitalization status. The company is currently overcoming a temporary slump in demand driven by partner inventory optimization.

NOVT (Novanta Corp) Company Total Assets history from 07/04/2022 to 10/29/2026

Financial and market metric breakdowns for Novanta Corp (NOVT)

- share price and expert price forecast:
Price novanta.com|NOVT - Consensus Target
- market capitalization indicators:
Market Value Novanta Photonics|NOVT - Enterprise Value
- balance sheet net asset value indicators:
Accounting Value of a Share Novanta|NOVT - Book Capitalization|Market-to-Book Ratio novanta.com|NOVT - Aggregate Company Assets
- debt burden and liquidity indicators:
All Debt to Shareholders' Equity Ratio Novanta Inc.|NOVT - Long-Term Debt to Capital|Short-Term Debt to Capital Novanta Photonics|NOVT - Company Debts|Debts to Book Capitalization Ratio Novanta Photonics|NOVT - Company Long-Term Debts|Short-Term Debt Novanta|Quick Ratio novanta.com
- net income and valuation multiples indicators:
NOVT - Net Income
Basic company analysis:novanta.com NOVT
Manufactured products of Novanta Corp

Total assets represent the company's aggregate resource base, reverse-calculated via return on assets (ROA) for the operational monitoring of balance sheet stability. The price action of the total asset value reflects capital sensitivity to operating profit, which is critical for Novanta Inc. (NOVT) during the modernization of toxic material control assembly lines and the implementation of local energy-saving technologies.

Direct competitors

DXCM: Aggregate Business Assets|Cumulative Company Assets PEN|HAE (Haemonetics Corp) - Aggregate Business Assets|Company Total Assets INSP|PRCT (Procept) - Aggregate Asset Value|Company Total Assets CNMD (CONMED Corporation)|pulsebiosciences.com (PLSE) - Company Assets|INMD - Aggregate Company Assets|Aggregate Asset Value PMI (Picard Medical Corp)|SRDX: Company Total Assets|Senseonics Holdings, Inc. (SENS) - Company Total Assets|Aggregate Company Assets NeuroPace, Inc.|Tactile Systems Technology Inc. - Total Asset Value of Company|Company Total Assets SNWV|OM - Company Assets|Electromed - Cumulative Company Assets|Company Total Assets LENSAR Inc LNSR|RCEL: Cumulative Company Assets|Profound Medical Corp. - Aggregate Business Assets|BDMD: Company Total Assets|EDAP - Company Total Asset Base|APYX (Apyx Medical Corp) - Company Total Assets|Cumulative Company Assets IceCure Medical, Ltd. (ICCM)|Cumulative Company Assets LUNG (Pulmonx Corporation)|TELA (telabio.com) - Aggregate Asset Value|Aggregate Company Assets CytoSorbents Corporation CTSO|SRTS - Cumulative Company Assets|Zynex Inc - Company Total Assets|Company Assets electroCore, Inc.|RBOT: Company Total Assets|Total Business Assets IINN|ICU (SeaStar Medical) - Company Total Assets|IRIDEX Corp. (IRIX) - Company Total Asset Base|Company Total Assets INBS|Cumulative Company Assets beyondair.net XAIR|Company Total Assets PFSA (Profusa Inc)|Company Total Assets STRATA Skin Sciences Inc. SSKN|GCTK - Aggregate Company Assets|NAOV: Aggregate Company Assets|VERO (Venus Concept Corp) - Cumulative Company Assets|Nuwellis Corp - Aggregate Asset Value|AEMD (Aethlon Medical) - Company Total Assets|Company Assets TransEnterix ASXC|Aggregate Company Assets Avinger (AVGR)|BioSig Technologies (BSGM) - Company Balance Sheet Assets|Cutera, Inc - Cumulative Company Assets|Company Total Assets Know Labs Corporation KNW|Inari Medical, Inc. - Company Total Assets|Company Total Asset Base nevro.com NVRO|reshapelifesciences.com (RSLS) - Aggregate Company Assets|Total Asset Value of Company SILK (Silk Road Medical, Inc.)